• NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts
  • Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak
  • Brineura Shows Promise Delaying Disease Progression in Children with CLN2, Review Suggests
  • NORD Opens COVID-19 Financial Aid Program for Rare Disease Community
  • Rare Disease Therapy Development: Finding a Way Forward
  • Axovant, Invitae Offering Free Genetic Testing, Counseling for Lysosomal Storage Diseases
  • FDA Favors Clinical Trial of Potential Juvenile Batten Treatment, PLX-200
  • NORD’s Advice on COVID-19: You’re Stronger Than You Think
  • NORD Partners with ‘Sing Me a Story’ for July 18–20 Living Rare Forum
  • Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19